IBX — Imagion Biosystems Balance Sheet
0.000.00%
Last trade - 00:00- AU$2.62m
- AU$2.79m
- AU$1.17m
Annual balance sheet for Imagion Biosystems, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 13.2 | 13.4 | 4.45 | 0.227 | 2.67 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | 0.201 | 0.226 | 0.216 | 0.034 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13.4 | 13.8 | 4.99 | 0.601 | 2.79 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.685 | 0.346 | 4.99 | 3.98 | 0.018 |
| Total Assets | 14.1 | 14.1 | 9.98 | 4.59 | 2.8 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.901 | 0.776 | 1.73 | 5.13 | 5.09 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.21 | 0.81 | 5.3 | 8.37 | 5.09 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 12.9 | 13.3 | 4.68 | -3.79 | -2.28 |
| Total Liabilities & Shareholders' Equity | 14.1 | 14.1 | 9.98 | 4.59 | 2.8 |
| Total Common Shares Outstanding |